According to Compass Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.50. In 2022 the company made an earnings per share (EPS) of -$0.60 an increase over its 2021 EPS that were of -$2.12.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -$0.47 | |
2022 | -$0.60 | -71.76% |
2021 | -$2.12 | 36.46% |
2020 | -$1.55 | 43.99% |
2019 | -$1.08 | -9.25% |
2018 | -$1.19 |